As battlefield medical systems face mounting pressure during intense combat operations, the U.S. Defense Advanced Research Projects Agency (DARPA) is exploring the possibility of deploying robotic medics to assist injured soldiers on the front lines.
Under a new Small Business Innovation Research solicitation, DARPA is seeking concepts for autonomous robotic swarms capable of locating wounded personnel, transporting them to safety, and delivering emergency medical aid. The envisioned systems could work together to pull casualties away from danger, administer critical medications, and even transform into supportive structures such as splints for broken limbs.
According to the solicitation, the agency aims to develop an “autonomous, self-deploying” robotic system able to assess wounds, coordinate in swarms, link together physically, and provide lifesaving support directly at the point of injury. Proposals are due by June 3.
DARPA noted that current battlefield medical practices were largely designed around smaller counterinsurgency missions and may prove inadequate during future large-scale conflicts involving high casualty rates, delayed evacuations, and overstretched medical resources.
The agency warned that delays in treatment significantly increase the risk of death from uncontrolled bleeding, which remains one of the leading causes of preventable fatalities in both military and civilian trauma situations before hospital care is available.
DARPA believes recent advances in swarm robotics, self-assembling machines, and medical robotics make these futuristic systems increasingly feasible.
To qualify, proposed solutions must address at least two of four operational goals outlined in the solicitation. One requirement involves robots capable of dragging injured soldiers roughly 10 meters onto a stretcher. If a single machine lacks the necessary strength, multiple robots should be able to combine forces to move the casualty together.
Another concept involves robots wrapping around damaged limbs to stabilize injuries during transport. DARPA is also interested in robotic systems capable of administering medication and forming autonomous tourniquets to control severe bleeding.
The solicitation describes “smart tourniquets” that could independently position themselves around wounded limbs, apply pressure to halt arterial bleeding, and stabilize difficult junctional wounds.
DARPA also sees these robotic systems working alongside unmanned evacuation vehicles already being explored by the U.S. Army. Due to their compact size, the robotic medics could operate effectively inside cramped autonomous evacuation platforms.
While DARPA is open to a wide variety of robot designs, it prefers systems small enough to fit inside an Individual First Aid Kit or lightweight enough for deployment by drone swarms.
The project’s first phase focuses on demonstrating core capabilities such as swarming behavior, injury identification, movement across rugged terrain, navigation around the human body, and the ability to interlock, reshape, and maintain structural stability. These tests may be conducted in laboratories or using medical training manikins.
In the second phase, developers must produce field-ready prototypes for testing with advanced medical simulators, perfused cadavers, or animal models. Participating companies will also need to present manufacturing plans that comply with U.S. Food and Drug Administration standards.
Beyond military use, DARPA believes swarming medic robots could play a valuable role in civilian disaster response. The agency noted that situations involving collapsed buildings, fires, or hazardous materials can prevent human rescuers from quickly reaching victims, while robotic systems could deliver immediate lifesaving assistance until emergency teams arrive.
